Search tips
Search criteria 


Logo of jmedgeneJournal of Medical GeneticsVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
J Med Genet. 2004 May; 41(5): 327–333.
PMCID: PMC1735760

Genotype–phenotype correlations in Peutz-Jeghers syndrome


Background and aims: Peutz-Jeghers syndrome (PJS) is a dominantly inherited disorder often caused by mutations in STK11. Time to onset of symptoms was characterised for a large collection of individuals with PJS who had been tested for STK11 mutations and genotype–phenotype correlations were evaluated.

Methods: We characterised mutations in 42 independent probands and also used a historical cohort design to study 51 individuals with Peutz-Jeghers syndrome who had completed self-administered questionnaires.

Results: Mutations were detected in 22/32 (69%) probands with PJS and 0/10 probands referred to rule out PJS. Real-time PCR analysis to quantitate DNA failed to detect any large deletions in PJS participants without STK11 mutations. The median time to onset for gastrointestinal symptoms or polypectomy was 13 years of age but showed a wide variability. Gastric polyps were frequent in PJS participants, with a median age at onset of 16 years. Individuals with missense mutations had a significantly later time to onset of first polypectomy (p = 0.04) and of other symptoms compared with those participants either with truncating mutations or no detectable mutation.

Conclusion: STK11 mutation analysis should be restricted to individuals who meet PJS criteria or their close relatives. Direct sequencing of STK11 yields a high rate of point mutations in individuals who meet phenotypic PJS criteria. Individuals with missense mutations of STK11 typically had a later time to onset for PJS symptoms. The common occurrence of gastric polyps may facilitate chemopreventive studies for this disorder.

Full Text

The Full Text of this article is available as a PDF (445K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Finan MC, Ray MK. Gastrointestinal polyposis syndromes. Dermatol Clin. 1989 Jul;7(3):419–434. [PubMed]
  • Lindor NM, Greene MH. The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst. 1998 Jul 15;90(14):1039–1071. [PubMed]
  • JEGHERS H, McKUSICK VA, KATZ KH. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. N Engl J Med. 1949 Dec 22;241(25):993–passim. [PubMed]
  • McGarrity TJ, Kulin HE, Zaino RJ. Peutz-Jeghers syndrome. Am J Gastroenterol. 2000 Mar;95(3):596–604. [PubMed]
  • BARTHOLOMEW LG, DAHLIN DC, WAUGH JM. Intestinal polyposis associated with mucocutaneous melanin pigmentation Peutz-Jeghers syndrome; review of literature and report of six cases with special reference to pathologic findings. Gastroenterology. 1957 Mar;32(3):434–451. [PubMed]
  • Spigelman AD, Arese P, Phillips RK. Polyposis: the Peutz-Jeghers syndrome. Br J Surg. 1995 Oct;82(10):1311–1314. [PubMed]
  • Choi HS, Park YJ, Youk EG, Yoon KA, Ku JL, Kim NK, Kim SM, Kim YJ, Moon DJ, Min JS, et al. Clinical characteristics of Peutz-Jeghers syndrome in Korean polyposis patients. Int J Colorectal Dis. 2000 Feb;15(1):35–38. [PubMed]
  • Hizawa K, Iida M, Matsumoto T, Kohrogi N, Kinoshita H, Yao T, Fujishima M. Cancer in Peutz-Jeghers syndrome. Cancer. 1993 Nov 1;72(9):2777–2781. [PubMed]
  • Boardman LA, Thibodeau SN, Schaid DJ, Lindor NM, McDonnell SK, Burgart LJ, Ahlquist DA, Podratz KC, Pittelkow M, Hartmann LC. Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med. 1998 Jun 1;128(11):896–899. [PubMed]
  • Giardiello FM, Brensinger JD, Tersmette AC, Goodman SN, Petersen GM, Booker SV, Cruz-Correa M, Offerhaus JA. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology. 2000 Dec;119(6):1447–1453. [PubMed]
  • Jenne DE, Reimann H, Nezu J, Friedel W, Loff S, Jeschke R, Müller O, Back W, Zimmer M. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet. 1998 Jan;18(1):38–43. [PubMed]
  • Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff M, Höglund P, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature. 1998 Jan 8;391(6663):184–187. [PubMed]
  • Olschwang S, Markie D, Seal S, Neale K, Phillips R, Cottrell S, Ellis I, Hodgson S, Zauber P, Spigelman A, et al. Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3. J Med Genet. 1998 Jan;35(1):42–44. [PMC free article] [PubMed]
  • Mehenni H, Gehrig C, Nezu J, Oku A, Shimane M, Rossier C, Guex N, Blouin JL, Scott HS, Antonarakis SE. Loss of LKB1 kinase activity in Peutz-Jeghers syndrome, and evidence for allelic and locus heterogeneity. Am J Hum Genet. 1998 Dec;63(6):1641–1650. [PubMed]
  • Tomlinson IP, Olschwang S, Abelovitch D, Nakamura Y, Bodmer WF, Thomas G, Markie D. Testing candidate loci on chromosomes 1 and 6 for genetic linkage to Peutz-Jeghers' disease. Ann Hum Genet. 1996 Sep;60(Pt 5):377–384. [PubMed]
  • Buchet-Poyau K, Mehenni H, Radhakrishna U, Antonarakis SE. Search for the second Peutz-Jeghers syndrome locus: exclusion of the STK13, PRKCG, KLK10, and PSCD2 genes on chromosome 19 and the STK11IP gene on chromosome 2. Cytogenet Genome Res. 2002;97(3-4):171–178. [PubMed]
  • Nickerson DA, Tobe VO, Taylor SL. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res. 1997 Jul 15;25(14):2745–2751. [PMC free article] [PubMed]
  • Ewing B, Hillier L, Wendl MC, Green P. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res. 1998 Mar;8(3):175–185. [PubMed]
  • Ewing B, Green P. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res. 1998 Mar;8(3):186–194. [PubMed]
  • Gordon D, Abajian C, Green P. Consed: a graphical tool for sequence finishing. Genome Res. 1998 Mar;8(3):195–202. [PubMed]
  • Lipsitz SR, Parzen M. A jackknife estimator of variance for Cox regression for correlated survival data. Biometrics. 1996 Mar;52(1):291–298. [PubMed]
  • Amos CI, Bali D, Thiel TJ, Anderson JP, Gourley I, Frazier ML, Lynch PM, Luchtefeld MA, Young A, McGarrity TJ, et al. Fine mapping of a genetic locus for Peutz-Jeghers syndrome on chromosome 19p. Cancer Res. 1997 Sep 1;57(17):3653–3656. [PubMed]
  • Dong SM, Kim KM, Kim SY, Shin MS, Na EY, Lee SH, Park WS, Yoo NJ, Jang JJ, Yoon CY, et al. Frequent somatic mutations in serine/threonine kinase 11/Peutz-Jeghers syndrome gene in left-sided colon cancer. Cancer Res. 1998 Sep 1;58(17):3787–3790. [PubMed]
  • Yoo Lina I, Chung Daniel C, Yuan Junying. LKB1--a master tumour suppressor of the small intestine and beyond. Nat Rev Cancer. 2002 Jul;2(7):529–535. [PubMed]
  • Boudeau Jérôme, Sapkota Gopal, Alessi Dario R. LKB1, a protein kinase regulating cell proliferation and polarity. FEBS Lett. 2003 Jul 3;546(1):159–165. [PubMed]
  • Foley TR, McGarrity TJ, Abt AB. Peutz-Jeghers syndrome: a clinicopathologic survey of the "Harrisburg family" with a 49-year follow-up. Gastroenterology. 1988 Dec;95(6):1535–1540. [PubMed]
  • Ylikorkala A, Avizienyte E, Tomlinson IP, Tiainen M, Roth S, Loukola A, Hemminki A, Johansson M, Sistonen P, Markie D, et al. Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer. Hum Mol Genet. 1999 Jan;8(1):45–51. [PubMed]
  • Yoon KA, Ku JL, Choi HS, Heo SC, Jeong SY, Park YJ, Kim NK, Kim JC, Jung PM, Park JG. Germline mutations of the STK11 gene in Korean Peutz-Jeghers syndrome patients. Br J Cancer. 2000 Apr;82(8):1403–1406. [PMC free article] [PubMed]
  • Boardman LA, Pittelkow MR, Couch FJ, Schaid DJ, McDonnell SK, Burgart LJ, Ahlquist DA, Carney JA, Schwartz DI, Thibodeau SN, et al. Association of Peutz-Jeghers-like mucocutaneous pigmentation with breast and gynecologic carcinomas in women. Medicine (Baltimore) 2000 Sep;79(5):293–298. [PubMed]
  • Boardman LA, Couch FJ, Burgart LJ, Schwartz D, Berry R, McDonnell SK, Schaid DJ, Hartmann LC, Schroeder JJ, Stratakis CA, et al. Genetic heterogeneity in Peutz-Jeghers syndrome. Hum Mutat. 2000;16(1):23–30. [PubMed]
  • Olschwang S, Boisson C, Thomas G. Peutz-Jeghers families unlinked to STK11/LKB1 gene mutations are highly predisposed to primitive biliary adenocarcinoma. J Med Genet. 2001 Jun;38(6):356–360. [PMC free article] [PubMed]
  • Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000 Jun 29;342(26):1946–1952. [PubMed]
  • Sandler Robert S, Halabi Susan, Baron John A, Budinger Susan, Paskett Electra, Keresztes Roger, Petrelli Nicholas, Pipas J Marc, Karp Daniel D, Loprinzi Charles L, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med. 2003 Mar 6;348(10):883–890. [PubMed]
  • McGarrity Thomas J, Peiffer Laurie P, Amos Christopher I, Frazier Marsha L, Ward Margaret G, Howett Mary K. Overexpression of cyclooxygenase 2 in hamartomatous polyps of Peutz-Jeghers syndrome. Am J Gastroenterol. 2003 Mar;98(3):671–678. [PubMed]
  • Wei Chongjuan, Amos Christopher I, Rashid Asif, Sabripour Mahyar, Nations Linda, McGarrity Thomas J, Frazier Marsha L. Correlation of staining for LKB1 and COX-2 in hamartomatous polyps and carcinomas from patients with Peutz-Jeghers syndrome. J Histochem Cytochem. 2003 Dec;51(12):1665–1672. [PubMed]
  • Rossi Derrick J, Ylikorkala Antti, Korsisaari Nina, Salovaara Reijo, Luukko Keijo, Launonen Virpi, Henkemeyer Mark, Ristimaki Ari, Aaltonen Lauri A, Makela Tomi P. Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis. Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12327–12332. [PubMed]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group